| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.12▲ | 1.12▲ | 1.07▲ | 0.92▲ | 1.29▼ |
| MA10 | 1.12▲ | 1.00▲ | 0.96▲ | 1.03▲ | 1.53▼ |
| MA20 | 0.99▲ | 0.89▲ | 0.91▲ | 1.27▼ | 2.77▼ |
| MA50 | 0.93▲ | 1.04▲ | 1.12▲ | 1.55▼ | 5.07▼ |
| MA100 | 1.10▲ | 1.25▼ | 1.33▼ | 2.87▼ | 13.22▼ |
| MA200 | 1.31▼ | 1.44▼ | 1.54▼ | 4.51▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | 0.049▲ | 0.052▲ | -0.003▼ | 0.082▲ |
| RSI | 66.230▲ | 62.785▲ | 63.428▲ | 40.560▼ | 24.559▼ |
| STOCH | 56.987 | 83.948▲ | 77.613 | 38.616 | 8.265▼ |
| WILL %R | -21.674▲ | -14.444▲ | -13.576▲ | -45.794 | -91.118▼ |
| CCI | 59.849 | 103.150▲ | 122.731▲ | -18.244 | -110.899▼ |
|
Monday, January 05, 2026 07:02 AM
Skye Bioscience Inc. (NASDAQ:SKYE) shares gained 5.3% in premarket trading on Monday after the company revealed a collaboration with Halozyme Therapeutics (NASDAQ:HALO) to develop a subcutaneous ...
|
|
Thursday, December 04, 2025 07:55 AM
NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skye Biosciences, Inc. ("Skye" or the "Company") (NYSE: ...
|
|
Tuesday, November 25, 2025 12:43 PM
Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 1.14 | 1.22 | 1.0001 | 1.09 | 65,156 |
| 12/11/26 | 0.8914 | 1.2701 | 0.80 | 1.08 | 159,834 |
| 11/11/26 | 0.8839 | 0.919 | 0.84 | 0.919 | 85,469 |
| 10/11/26 | 0.825 | 1.04 | 0.7111 | 0.839 | 1,658,686 |
| 09/11/26 | 0.97 | 0.9769 | 0.51 | 0.69 | 69,697 |
| 06/11/26 | 1.09 | 1.09 | 0.9801 | 0.9903 | 20,995 |
| 05/11/26 | 1.13 | 1.1601 | 1.04 | 1.04 | 35,448 |
| 04/11/26 | 1.25 | 1.30 | 1.11 | 1.14 | 40,100 |
| 03/11/26 | 1.2801 | 1.35 | 1.22 | 1.22 | 30,119 |
| 02/11/26 | 1.28 | 1.36 | 1.28 | 1.32 | 9,677 |
|
|
||||
|
|
||||
|
|